drugset / Trial / NCT00840216
Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the relative bioequivalence of a test clarithromycin extended release formulation to an equivalent oral dose of the commercially available extended release clarithromycin in a test population of 22 adult subjects under fed conditions.
Timeline
- Start
- 2002-08
- Primary completion
- 2002-08
- Completion
- 2002-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | 500 mg | Oral |
Indications
No indication recorded.